Press release
Liver Failure Market is projected to reach USD 9.63 billion by 2034
Liver Failure
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71145
Liver failure occurs when large portions of the liver become severely damaged, impairing the organ's ability to function. It may present as acute liver failure (ALF)-a rapid onset condition often caused by toxins, infections, or drugs-or chronic liver failure (CLF), which develops progressively due to long-term hepatic injury. Without appropriate intervention, liver failure can lead to multi-organ dysfunction and carries a high mortality risk, making timely diagnosis and treatment essential.
Key Market Highlights
• 2024 Market Size: USD 5.72 billion
• 2034 Forecast: USD 9.63 billion
• CAGR (2025-2034): 5.4%
• Largest Segment: Chronic liver failure therapeutics
• Fastest-Growing Segment: Artificial liver support systems & regenerative therapies
Epidemiology & Clinical Insights
1. Global Burden
• Liver failure accounts for over 2 million deaths annually worldwide.
• Major causes include viral hepatitis, MASH/MASLD, alcohol-related cirrhosis, and DILI.
• Acute liver failure remains rare but carries a high mortality rate without transplantation.
2. Types of Liver Failure
• Acute Liver Failure (ALF): rapid decline in liver function; causes include acetaminophen toxicity, hepatitis viruses, autoimmune hepatitis, Wilson's disease, and acute ischemia.
• Chronic Liver Failure (CLF): progressive outcome of cirrhosis due to viral, metabolic, autoimmune, or alcohol-related liver disease.
3. Key Symptoms
• Jaundice
• Coagulopathy
• Hepatic encephalopathy
• Ascites
• Multiorgan dysfunction
4. Diagnostic Tools
• Liver enzyme panels
• Coagulation tests
• Ultrasound & elastography
• CT/MRI
• Biopsy
• Biomarkers predicting hepatic decompensation and transplant need
Market Growth Drivers
1. Increasing Global Burden of Chronic Liver Disease
Obesity, diabetes, metabolic syndrome, and alcohol consumption continue to rise, driving CLF cases.
2. Advancements in Transplantation & Organ Preservation
Improved graft preservation, living donor transplant programs, and expanded organ criteria.
3. Growing Adoption of Artificial Liver Support Systems
Extracorporeal liver assist devices (e.g., MARS, ELAD) supplement liver function during acute failure.
4. Development of Regenerative & Stem Cell Therapies
Stem cell-based hepatocyte regeneration and bio-artificial liver platforms show strong potential.
5. Increased Hepatitis Screening & Treatment
HBV vaccination and HCV curative therapies reduce long-term liver failure incidence.
Market Restraints
• Shortage of donor organs for transplantation
• High cost of advanced therapies and critical care
• Limited availability of specialized liver units in developing regions
• Risks associated with immunosuppressive therapy post-transplant
Market Opportunities
1. Next-Generation Bio-Artificial Liver Devices
Devices combining hepatocyte cultures with extracorporeal filtration.
2. Stem Cell-Based Regenerative Technologies
Mesenchymal stem cells (MSCs), induced pluripotent stem cells (iPSCs), and liver organoids.
3. AI-Based Clinical Decision Support
Predicting acute decompensation, transplant need, and patient outcomes.
4. Early Detection Biomarkers
Non-invasive markers to predict progression from compensated to decompensated liver disease.
5. Expansion of Living Donor Liver Transplant Programs
Improves access and reduces waitlist mortality.
Segmentation Overview
By Disease Type
• Acute liver failure
• Chronic liver failure (cirrhosis-induced)
By Cause
• Viral hepatitis
• MASH/MASLD
• Alcohol-related liver disease
• Autoimmune liver disease
• Drug-induced liver injury
• Genetic/metabolic disorders
By Treatment
• Supportive medical therapy
• Liver transplantation
• Artificial liver support (MARS, ELAD, Prometheus)
• Regenerative therapies (stem cells, hepatocyte infusions)
• Antiviral & disease-specific therapies
By End User
• Hospitals
• Transplant centers
• Specialized liver units
• Research institutions
Explore Full Report here: https://exactitudeconsultancy.com/reports/71145/liver-failure-market
Regional Insights
North America - Largest Market
High incidence of MASH/NASH and alcohol-related liver disease, strong transplantation infrastructure.
Europe - Strong Adoption of Extracorporeal Liver Support
Germany, UK, France, and Italy lead in clinical use of MARS and advanced critical care.
Asia Pacific - Fastest Growing
High burden of hepatitis B, expanding liver transplant programs in India, China, South Korea, and Japan.
Latin America - Developing
Improving access to viral hepatitis treatment and liver transplantation.
Middle East & Africa - Emerging
Government investment in specialized hepatology and transplant centers.
Competitive Landscape
Leading companies active in the liver failure therapeutics and support systems market include:
• Baxter International
• Fresenius Medical Care
• Vital Therapies
• Gilead Sciences
• Novartis
• AbbVie
• Merck & Co.
• Medtronic
• Terumo Corporation
• Nikkiso Co.
Key focus areas include extracorporeal liver support, hepatocyte-based biologics, antiviral therapy, and transplant care solutions.
Recent Market Developments
• Expansion of MARS and Prometheus liver assist systems in critical care units
• Advancements in organ perfusion techniques improving transplant outcomes
• Increasing clinical trials for stem cell-based regenerative therapies
• Novel biomarkers predicting acute decompensation and mortality risk
• Growing adoption of HCV curative regimens reducing long-term liver failure burden
Future Outlook (2025-2034)
The Liver Failure Market is expected to grow significantly as:
• Innovative bio-artificial liver devices become clinically validated
• Transplantation and organ preservation technologies improve
• Regenerative therapies move toward mainstream adoption
• AI and predictive diagnostics enhance early management
• Chronic liver disease burden continues rising globally
By 2034, the market is projected to reach USD 9.63 billion, driven by therapeutic innovation, rising disease burden, and expanding access to specialized hepatology care.
This report is also available in the following languages : Japanese (肝不全市場), Korean (간부전 시장), Chinese (肝衰竭市场), French (Marché de l'insuffisance hépatique), German (Markt für Leberversagen), and Italian (Mercato dell'insufficienza epatica), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/request-sample/71145
Our More Reports:
Cancer Diagnostics Market
https://exactitudeconsultancy.com/reports/10927/cancer-diagnostics-market
Human Liver Models Market
https://exactitudeconsultancy.com/reports/30377/human-liver-models-market
Oncology Nutrition Market
https://exactitudeconsultancy.com/reports/31361/oncology-nutrition-market
Tumor Ablation Market
https://exactitudeconsultancy.com/reports/48452/tumor-ablation-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Liver Failure Market is projected to reach USD 9.63 billion by 2034 here
News-ID: 4311202 • Views: …
More Releases from Exactitude Consultancy
Opioid-Induced Constipation (OIC) Market is projected to reach USD 3.48 billion …
The global Opioid-Induced Constipation (OIC) Market was valued at USD 2.06 billion in 2024 and is projected to reach USD 3.48 billion by 2034, growing at a CAGR of 5.2% during 2025-2034. Rising opioid usage for chronic non-cancer and cancer-related pain, along with increasing awareness of OIC-specific therapies, is fueling ongoing market expansion. Unlike general constipation, OIC results directly from opioid activity on gastrointestinal μ-receptors, making traditional laxatives insufficient for…
Hemorrhoids Market is projected to reach USD 4.64 billion by 2034
The global Hemorrhoids Market was valued at USD 2.87 billion in 2024 and is projected to reach USD 4.64 billion by 2034, growing at a CAGR of 4.9% during the forecast period (2025-2034). This growth is driven by increasing prevalence of chronic constipation, sedentary lifestyles, obesity, pregnancy-related hemorrhoids, and expanding adoption of minimally invasive treatment options such as rubber band ligation, infrared coagulation, and laser therapy.
Download Full PDF Sample Copy…
Gastritis Market is projected to reach USD 3.91 billion by 2034
The global Gastritis Market was valued at USD 2.34 billion in 2024 and is projected to reach USD 3.91 billion by 2034, growing at a CAGR of 5.3% during the forecast period (2025-2034). Growth is driven by rising global prevalence of Helicobacter pylori (H. pylori) infection, increasing NSAID-related gastric inflammation, rising alcohol consumption, expanding geriatric populations, and the increasing availability of advanced diagnostic tests and effective eradication therapies.
Download Full PDF…
Functional Constipation Market is projected to reach USD 14.77 billion by 2034
The global Functional Constipation Market was valued at USD 8.92 billion in 2024 and is projected to reach USD 14.77 billion by 2034, growing at a CAGR of 5.1% over the forecast period (2025-2034). The market's growth is driven by increasing prevalence of chronic gastrointestinal motility disorders, sedentary lifestyles, rising geriatric populations, expanded awareness of bowel health, and the adoption of novel prescription laxatives and prokinetic agents.
Download Full PDF Sample…
More Releases for Liver
Rising Liver Disease Cases Drive Growth In Liver Metastases Treatment Market Dri …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Liver Metastases Treatment Market Size By 2025?
The market for treating liver metastases has seen significant growth in the past few years. It is projected to increase from $1.57 billion in 2024 to $1.71 billion in 2025, with a compound annual growth rate (CAGR) of…
LivCare Liver Support
The liver plays a crucial role in maintaining overall well-being, performing essential functions like detoxification, digestion, and metabolism. However, many people overlook the importance of liver health until problems arise. LivCare Liver Support is a premium supplement designed to keep your liver in peak condition. By incorporating this supplement into your daily routine, you can help ensure your liver functions optimally, leading to better overall health.
● Product Name - LivCare…
Liver Cancer Therapeutics Market - Empowering Recovery, Restoring Health: Innova …
Newark, New Castle, USA - new report, titled Liver Cancer Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Liver Cancer Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Liver Cancer Therapeutics market. The report offers an overview of…
Liver Health Supplements Market Grows Strong as Consumers Adopt Proactive Measur …
Global liver health supplements market was valued at US$ 8.7 Bn in 2021, is growing at an estimated CAGR of 5.8% over the forecast period (2022 - 2030). The liver health supplements market is growing due to the increasing awareness of the importance of liver health and the rise of lifestyle-related liver diseases. The market offers a wide range of supplements that help in improving liver function, supporting liver detoxification,…
Urgent Liver 911 Reviews 2021: Is Urgent Liver 911 Legit?
Urgent Liver 911 by PhytAge Laboratories is a powerful diet that promotes liver function by combining natural minerals and nutrients. The diet is made up of plant and herbal extracts that collectively aid in liver cell protection. While the liver is an important human organ that promotes general health and vitality, most people are unaware that even those who appear to be in good health can be affected by liver…
Liver Extract Power Exporter, Liver Extract Product, Liver Extract Crude, Liver …
Titan Biotech is an ISO 9001:2000 Certified Company, established with an objective of serving Scientific Community and providing good quality of Biological Products, Biotechnology Products, Biological Extracts and their derivatives. Liver Extract Power Exporter is produced from specific fraction of beef liver. Liver Extract is rich in vital nutrients including energy producing B Vitamins and serve as an excellent source of proteins. Liver Extract is capable of stimulating the production…
